Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,NRF2 pathway WP2884,2.4469333028072962e-06,8.85333642261353,114.39108285311765,"['EGR1', 'NQO1', 'HSP90AA1', 'HGF', 'HMOX1', 'SLC5A3', 'SLC39A14', 'EPHA2', 'HSPA1A']",0.0006117333257018241,0,0,9
2,Nuclear Receptors Meta-Pathway WP2882,9.705353399112446e-06,5.241622574955908,60.50317365371107,"['EGR1', 'NQO1', 'HSP90AA1', 'HGF', 'HMOX1', 'IRS2', 'HES1', 'SLC5A3', 'SLC39A14', 'HSPA1A', 'NFKB2', 'EPHA2']",0.0012131691748890558,0,0,12
3,Complement system WP2806,0.00012657297078654114,11.751838235294118,105.46912356515463,"['C1R', 'PROS1', 'CFI', 'F11', 'SERPING1']",0.009126206390297124,0,0,5
4,Complement and Coagulation Cascades WP558,0.00018434033103561134,16.738803530565544,143.9323999177749,"['C1R', 'PROS1', 'CFI', 'SERPING1']",0.009126206390297124,0,0,4
5,MAPK Signaling Pathway WP382,0.00019279781283690017,4.4062772449869225,37.690716216546484,"['NR4A1', 'EGF', 'IL1R1', 'GADD45A', 'HSPB1', 'MAP3K6', 'MAP3K14', 'HSPA1B', 'HSPA1A', 'NFKB2']",0.009126206390297124,0,0,10
6,Lung fibrosis WP3624,0.00021902895336713097,15.900621118012422,133.9835091435412,"['CEBPB', 'EGF', 'HGF', 'HMOX1']",0.009126206390297124,0,0,4
7,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.0003784524974627095,9.073863636363637,71.4967825686558,"['CEBPB', 'HMGA2', 'TNFRSF11B', 'HES1', 'HES5']",0.013516160623668198,0,0,5
8,IL-18 signaling pathway WP4754,0.0005262426053973235,4.21754112939084,31.84137365366071,"['ACTA2', 'NR4A1', 'SOCS3', 'CEBPB', 'HSPB1', 'HMOX1', 'TNFRSF11B', 'KLF2', 'NFKB2']",0.01644508141866636,0,0,9
9,The influence of laminopathies on Wnt signaling WP4844,0.0006052066968899721,11.771796641361858,87.22831281454489,"['CEBPB', 'HMGA2', 'HES1', 'HES5']",0.01653970040047943,0,0,4
10,Phytochemical activity on NRF2 transcriptional activation WP3,0.0006615880160191772,21.563973063973062,157.86699017986516,"['NQO1', 'CEBPB', 'HMOX1']",0.01653970040047943,0,0,3
11,Adipogenesis WP236,0.0011775400218981373,5.522880069399263,37.24811327760889,"['SOCS3', 'CEBPB', 'KLF6', 'GADD45A', 'EBF1', 'IRS2']",0.026762273224957667,0,0,6
12,Ebstein-Barr virus LMP1 signaling WP262,0.0014287686935474245,15.808641975308642,103.56150077492288,"['HSP90AA1', 'MAP3K14', 'NFKB2']",0.029766014448904678,0,0,3
13,Apoptosis Modulation and Signaling WP1772,0.0015955483657346527,6.430443548387097,41.41551473684562,"['IL1R1', 'BAG3', 'TNFRSF11B', 'MAP3K14', 'HSPA1A']",0.030683622417974087,0,0,5
14,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.0023279917688799013,39.31288343558282,238.34415593343746,"['SOCS3', 'CHI3L1']",0.04107830514521664,0,0,2
15,NRF2-ARE regulation WP4357,0.0025978619040250687,12.476608187134502,74.27407844295216,"['NQO1', 'CEBPB', 'HMOX1']",0.04107830514521664,0,0,3
16,Spinal Cord Injury WP2431,0.002629011529293865,5.691964285714286,33.81679851992696,"['EGR1', 'NR4A1', 'ZFP36', 'IL1R1', 'GADD45A']",0.04107830514521664,0,0,5
17,Vitamin D Receptor Pathway WP2877,0.00294917616079318,5.532986111111111,32.23644643423051,"['BCL6', 'GADD45A', 'S100A6', 'TNFRSF11B', 'PRKCQ']",0.041893064421478124,0,0,5
18,Breast cancer pathway WP4262,0.0031719279114062354,4.483512608005642,25.795511839062105,"['GADD45A', 'EGF', 'FZD9', 'HES1', 'HES5', 'NFKB2']",0.041893064421478124,0,0,6
19,Aryl Hydrocarbon Receptor Pathway WP2873,0.0033514451537182497,11.286596119929452,64.31512891527846,"['NQO1', 'HSP90AA1', 'HES1']",0.041893064421478124,0,0,3
20,White fat cell differentiation WP4149,0.0033514451537182497,11.286596119929452,64.31512891527846,"['CEBPB', 'EBF1', 'KLF2']",0.041893064421478124,0,0,3
21,Signal transduction through IL1R WP4496,0.0037732556378841818,10.772727272727273,60.10984769653105,"['IRAK2', 'IL1R1', 'MAP3K14']",0.04491970997481169,0,0,3
22,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.004235707507200687,6.6107660455486545,36.12258023813484,"['PLCG2', 'PRKCQ', 'IFI44L', 'NFKB2']",0.04813303985455326,0,0,4
23,IL17 signaling pathway WP2112,0.004710371679180065,9.873456790123457,52.90186755452863,"['CEBPB', 'MAP3K14', 'IL17RB']",0.05119969216500071,0,0,3
24,Oncostatin M Signaling Pathway WP2374,0.005181705298364738,6.220436000487151,32.735797552721785,"['SOCS3', 'EGR1', 'CEBPB', 'OSMR']",0.052392049763555756,0,0,4
25,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.005243445090510887,3.1990366638146845,16.79742665427381,"['EFNA1', 'HSP90AA1', 'EGF', 'HGF', 'TNC', 'IRS2', 'OSMR', 'EPHA2']",0.052392049763555756,0,0,8
26,Transcriptional cascade regulating adipogenesis WP4211,0.005448773175409799,22.459246275197195,117.0657847435443,"['CEBPB', 'KLF2']",0.052392049763555756,0,0,2
27,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.006754366412620558,19.650306748466257,98.20370700394706,"['FAM20C', 'NFKB2']",0.06254042974648664,0,0,2
28,VEGFA-VEGFR2 Signaling Pathway WP3888,0.0076585575424213,2.479307600477517,12.079017102781222,"['EGR1', 'NR4A1', 'HSP90AA1', 'EGR3', 'ADAMTS1', 'HSPB1', 'DSC1', 'NDRG1', 'APOLD1', 'HSPA1A', 'EPHA2']",0.06837997805733304,0,0,11
29,Leptin Insulin Overlap WP3935,0.008186802514741508,17.465576005453308,83.92614246134119,"['SOCS3', 'IRS2']",0.06926350181352875,0,0,2
30,Aryl Hydrocarbon Receptor Netpath WP2586,0.00831162021762345,7.895061728395062,37.81814084659849,"['NQO1', 'HSP90AA1', 'KLF6']",0.06926350181352875,0,0,3
31,Insulin Signaling WP481,0.009523331598951015,3.5194228634850164,16.37943107859443,"['SOCS3', 'EGR1', 'IRS2', 'PRKCQ', 'MAP3K6', 'MAP3K14']",0.07647009614165036,0,0,6
32,Ferroptosis WP4313,0.009788172306131247,7.400462962962963,34.23883785552624,"['TFRC', 'HMOX1', 'SLC39A14']",0.07647009614165036,0,0,3
33,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.01141869021421174,14.287785833798104,63.902176058159434,"['EGF', 'HSPB1']",0.08650522889554349,0,0,2
34,Corticotropin-releasing hormone signaling pathway WP2355,0.012035449179224122,4.801054018445323,21.220173306309935,"['NR4A1', 'HSP90AA1', 'PLCG2', 'PRKCQ']",0.08849594984723619,0,0,4
35,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.01309748081925098,3.7842261904761907,16.405889655972477,"['EGR1', 'CEBPB', 'HES1', 'HES5', 'NFKB2']",0.09355343442322128,0,0,5
36,PI3K-Akt signaling pathway WP4172,0.01908541252007454,2.712854860513703,10.739733860982605,"['EFNA1', 'HSP90AA1', 'EGF', 'HGF', 'TNC', 'OSMR', 'EPHA2']",0.12097888418217384,0,0,7
37,Transcription factor regulation in adipogenesis WP3599,0.019259508463759647,10.474437627811861,41.37141414769532,"['CEBPB', 'IRS2']",0.12097888418217384,0,0,2
38,Globo Sphingolipid Metabolism WP1424,0.019259508463759647,10.474437627811861,41.37141414769532,"['ST6GAL1', 'ST6GAL2']",0.12097888418217384,0,0,2
39,Monoamine Transport WP727,0.019259508463759647,10.474437627811861,41.37141414769532,"['IL1R1', 'TNFRSF11B']",0.12097888418217384,0,0,2
40,Genotoxicity pathway WP4286,0.019356621469147815,5.634038800705468,22.22470961275788,"['ACTA2', 'ITPKC', 'GADD45A']",0.12097888418217384,0,0,3
41,IL-4 signaling pathway WP395,0.020518166569292066,5.502583979328166,21.38548785384061,"['SOCS3', 'CEBPB', 'IRS2']",0.125110771763976,0,0,3
42,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.02148835668814594,9.819018404907975,37.70742690739034,"['NQO1', 'HMOX1']",0.12626340371699266,0,0,2
43,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.021717305439322737,5.377104377104377,20.592405465888564,"['IL1R1', 'IRAK2', 'MAP3K14']",0.12626340371699266,0,0,3
44,Integrated breast cancer pathway WP1984,0.022951031148047283,3.252561475409836,12.276443356535726,"['BARD1', 'ITPKC', 'RASGEF1A', 'GADD45A', 'PML']",0.127522541709677,0,0,5
45,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.02295405750774186,5.257201646090535,19.8420488308017,"['SOCS3', 'NQO1', 'HSPB1']",0.127522541709677,0,0,3
46,Ovarian infertility WP34,0.02381864871004758,9.240707325875135,34.5351702393491,"['EGR1', 'CEBPB']",0.12944917777199771,0,0,2
47,Metapathway biotransformation Phase I and II WP702,0.027640030685759976,3.678751986133179,13.201165339699884,"['CYP39A1', 'HS3ST3B1', 'CHST6', 'HS3ST3A1']",0.14679592371108693,0,0,4
48,IL-1 signaling pathway WP195,0.028276871215462417,4.826530612244898,17.210013682136537,"['IL1R1', 'IRAK2', 'MAP3K14']",0.14679592371108693,0,0,3
49,Differentiation Pathway WP2848,0.02877200104737304,8.266709719082984,29.333200516567256,"['EGF', 'HGF']",0.14679592371108693,0,0,2
50,Vitamin B12 metabolism WP1533,0.031389420512487436,7.852760736196319,27.1806379912188,"['SERPINA3', 'NFKB2']",0.14806330430418602,0,0,2
51,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.031389420512487436,7.852760736196319,27.1806379912188,"['HSP90AA1', 'NOD1']",0.14806330430418602,0,0,2
52,Oxidative Stress WP408,0.031389420512487436,7.852760736196319,27.1806379912188,"['NQO1', 'HMOX1']",0.14806330430418602,0,0,2
53,Pre-implantation embryo WP3527,0.031389420512487436,7.852760736196319,27.1806379912188,"['EGR1', 'ZFP36']",0.14806330430418602,0,0,2
54,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.03409700015774696,7.478235465965527,25.265561551985,"['P3H2', 'TNFRSF11B']",0.15498636435339527,0,0,2
55,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.03409700015774696,7.478235465965527,25.265561551985,"['HSPB1', 'NDRG1']",0.15498636435339527,0,0,2
56,Benzene metabolism WP3891,0.0376412157282944,39.079268292682926,128.16654367718792,['NQO1'],0.1594966768148068,0,0,1
57,EV release from cardiac cells and their functional effects WP3297,0.0376412157282944,39.079268292682926,128.16654367718792,['KLF2'],0.1594966768148068,0,0,1
58,Hypothetical Craniofacial Development Pathway WP3655,0.0376412157282944,39.079268292682926,128.16654367718792,['ARHGAP29'],0.1594966768148068,0,0,1
59,let-7 inhibition of ES cell reprogramming WP3299,0.0376412157282944,39.079268292682926,128.16654367718792,['EGR1'],0.1594966768148068,0,0,1
60,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.039771957013622176,6.826887169911976,22.01393403186456,"['ACTA2', 'PRKCQ']",0.16571648755675908,0,0,2
61,Oxysterols derived from cholesterol WP4545,0.04273412412550827,6.541922290388548,20.625094683572353,"['CYP39A1', 'HSD3B7']",0.17513985297339452,0,0,2
62,Neural Crest Differentiation WP2064,0.047800204736276684,3.873406193078324,11.777964426574457,"['HES1', 'HES5', 'NFKB2']",0.19274276103337373,0,0,3
63,Non-small cell lung cancer WP4255,0.04966166994154087,3.8106332138590204,11.441509570665922,"['EGF', 'GADD45A', 'PLCG2']",0.1959276851551791,0,0,3
64,TGF-beta Signaling Pathway WP366,0.05015748739972585,3.0085773439810706,9.003430879044195,"['KLF6', 'LIMK2', 'TNC', 'PML']",0.1959276851551791,0,0,4
65,DNA IR-damage and cellular response via ATR WP4016,0.05155814810113917,3.7498530276308055,11.118483041228474,"['BARD1', 'BCL6', 'PML']",0.19830056961976605,0,0,3
66,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.05587867108265252,2.8972591030827965,8.357354010915424,"['TRIP10', 'IRS2', 'MAP3K6', 'MAP3K14']",0.21166163288883533,0,0,4
67,Folate Metabolism WP176,0.05869221667972953,5.411889147450815,15.34513110271443,"['SERPINA3', 'NFKB2']",0.21578020838135856,0,0,2
68,Oxidative Damage WP3941,0.05869221667972953,5.411889147450815,15.34513110271443,"['C1R', 'GADD45A']",0.21578020838135856,0,0,2
69,Serotonin Transporter Activity WP1455,0.06194960583175311,19.536585365853657,54.33972343712793,['IL1R1'],0.22124859225626112,0,0,1
70,Osteoblast Signaling WP322,0.06194960583175311,19.536585365853657,54.33972343712793,['TNFRSF11B'],0.22124859225626112,0,0,1
71,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.06365635914259762,3.4221685453569513,9.425528423571969,"['EGF', 'HGF', 'PLCG2']",0.2241421096570339,0,0,3
72,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.06910003756688703,4.903374233128834,13.102796648072001,"['MAP3K14', 'NFKB2']",0.23664396427016104,0,0,2
73,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.06910003756688703,4.903374233128834,13.102796648072001,"['IFITM3', 'IFITM2']",0.23664396427016104,0,0,2
74,Fas ligand pathway and stress induction of heat shock proteins WP314,0.07269470039234317,4.754415318832497,12.463636971707567,"['HSPB1', 'LMNB1']",0.23924907093738113,0,0,2
75,Blood Clotting Cascade WP272,0.07387395121787643,15.628048780487806,40.71724015351707,['F11'],0.23924907093738113,0,0,1
76,PTF1A related regulatory pathway WP4147,0.07387395121787643,15.628048780487806,40.71724015351707,['HES1'],0.23924907093738113,0,0,1
77,TNF-alpha signaling pathway WP231,0.0746457101324629,3.18968968968969,8.277251835611857,"['HSP90AA1', 'MAP3K14', 'NFKB2']",0.23924907093738113,0,0,3
78,Wnt signaling pathway and pluripotency WP399,0.0746457101324629,3.18968968968969,8.277251835611857,"['FZD9', 'PRKCQ', 'CD44']",0.23924907093738113,0,0,3
79,Notch Signaling WP268,0.0838253784226373,4.357191547375597,10.801562690064875,"['HES1', 'HES5']",0.24897565474922334,0,0,2
80,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.08564762523373283,13.022357723577235,32.00262356677215,['NFKB2'],0.24897565474922334,0,0,1
81,Estrogen metabolism WP697,0.08564762523373283,13.022357723577235,32.00262356677215,['NQO1'],0.24897565474922334,0,0,1
82,Farnesoid X receptor pathway WP2879,0.08564762523373283,13.022357723577235,32.00262356677215,['IRS2'],0.24897565474922334,0,0,1
83,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.08564762523373283,13.022357723577235,32.00262356677215,['CEBPB'],0.24897565474922334,0,0,1
84,Gene regulatory network modelling somitogenesis  WP2854,0.08564762523373283,13.022357723577235,32.00262356677215,['HES1'],0.24897565474922334,0,0,1
85,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.08564762523373283,13.022357723577235,32.00262356677215,['HES1'],0.24897565474922334,0,0,1
86,Nephrogenesis WP5052,0.08564762523373283,13.022357723577235,32.00262356677215,['RSPO3'],0.24897565474922334,0,0,1
87,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.08764443396098917,4.239097993699221,10.319944907279245,"['PRKCQ', 'MAP3K14']",0.25185182172698034,0,0,2
88,Endochondral Ossification with Skeletal Dysplasias WP4808,0.09151464098261199,4.127219890216338,9.869240600128181,"['ADAMTS1', 'SLC38A2']",0.25598031497573026,0,0,2
89,Endochondral Ossification WP474,0.09151464098261199,4.127219890216338,9.869240600128181,"['ADAMTS1', 'SLC38A2']",0.25598031497573026,0,0,2
90,Modulators of TCR signaling and T cell activation WP5072,0.09543410211174487,4.021079125373604,9.446798795743247,"['PRKCQ', 'MAP3K14']",0.25598031497573026,0,0,2
91,Complement Activation WP545,0.09727251969077749,11.161149825783973,26.00814391175831,['C1R'],0.25598031497573026,0,0,1
92,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.09727251969077749,11.161149825783973,26.00814391175831,['HMOX1'],0.25598031497573026,0,0,1
93,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.09727251969077749,11.161149825783973,26.00814391175831,['EGF'],0.25598031497573026,0,0,1
94,Osteoclast Signaling WP12,0.09727251969077749,11.161149825783973,26.00814391175831,['TNFRSF11B'],0.25598031497573026,0,0,1
95,RAS and bradykinin pathways in COVID-19 WP4969,0.09727251969077749,11.161149825783973,26.00814391175831,['SERPING1'],0.25598031497573026,0,0,1
96,Exercise-induced Circadian Regulation WP410,0.10341339377142636,3.824330390543169,8.677485170563529,"['CEBPB', 'ETV6']",0.2693057129464228,0,0,2
97,Dopamine metabolism WP2436,0.10875050296097885,9.765243902439025,21.666136725786213,['NQO1'],0.27742475245147663,0,0,1
98,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.10875050296097885,9.765243902439025,21.666136725786213,['PRKCQ'],0.27742475245147663,0,0,1
99,Gastrin signaling pathway WP4659,0.11209615008273698,2.6489804411152726,5.797024275768448,"['EGR1', 'PRKCQ', 'CD44']",0.2830710860675176,0,0,3
100,Interferon type I signaling pathways WP585,0.11570653406925054,3.5627440044617957,7.683763482224999,"['SOCS3', 'IRS2']",0.28321561373179666,0,0,2
101,Selenium Micronutrient Network WP15,0.119883836142756,3.4832992501704156,7.388885964579659,"['SERPINA3', 'NFKB2']",0.28321561373179666,0,0,2
102,Cardiac Hypertrophic Response WP2795,0.119883836142756,3.4832992501704156,7.388885964579659,"['EGF', 'MAP3K14']",0.28321561373179666,0,0,2
103,RANKL/RANK signaling pathway WP2018,0.119883836142756,3.4832992501704156,7.388885964579659,"['TNFRSF11B', 'NFKB2']",0.28321561373179666,0,0,2
104,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.12008342022228179,8.679539295392955,18.396879032822266,['PRKCQ'],0.28321561373179666,0,0,1
105,Iron metabolism in placenta WP2007,0.12008342022228179,8.679539295392955,18.396879032822266,['TFRC'],0.28321561373179666,0,0,1
106,Osteopontin Signaling WP1434,0.12008342022228179,8.679539295392955,18.396879032822266,['MAP3K14'],0.28321561373179666,0,0,1
107,DNA damage response WP707,0.12834795691353157,3.334551625114215,6.845868798491215,"['GADD45A', 'PML']",0.29302029841254407,0,0,2
108,Glucocorticoid Receptor Pathway WP2880,0.12834795691353157,3.334551625114215,6.845868798491215,"['HSP90AA1', 'NFKB2']",0.29302029841254407,0,0,2
109,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.13127309368881973,7.810975609756097,15.859994146432374,['TNC'],0.29302029841254407,0,0,1
110,FOXA2 pathway WP5066,0.13127309368881973,7.810975609756097,15.859994146432374,['IRS2'],0.29302029841254407,0,0,1
111,"GPCRs, Class B Secretin-like WP334",0.13127309368881973,7.810975609756097,15.859994146432374,['CALCRL'],0.29302029841254407,0,0,1
112,GPR40 Pathway WP3958,0.13127309368881973,7.810975609756097,15.859994146432374,['PLCG2'],0.29302029841254407,0,0,1
113,miRNA regulation of DNA damage response WP1530,0.1369476004659179,3.1979466633279077,6.358019739456897,"['GADD45A', 'PML']",0.3003236852322761,0,0,2
114,p53 transcriptional gene network WP4963,0.1369476004659179,3.1979466633279077,6.358019739456897,"['GADD45A', 'PML']",0.3003236852322761,0,0,2
115,Notch Signaling Pathway Netpath WP61,0.14129443213177478,3.1337423312883437,6.132449808528157,"['HES1', 'HES5']",0.3015282263760681,0,0,2
116,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.14232132284950413,7.1003325942350335,13.843290827801507,['NFKB2'],0.3015282263760681,0,0,1
117,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.14232132284950413,7.1003325942350335,13.843290827801507,['MAP3K14'],0.3015282263760681,0,0,1
118,Overview of nanoparticle effects WP3287,0.14232132284950413,7.1003325942350335,13.843290827801507,['HMOX1'],0.3015282263760681,0,0,1
119,Regulatory circuits of the STAT3 signaling pathway WP4538,0.14567063679017953,3.0720558161915075,5.9180301914306375,"['SOCS3', 'OSMR']",0.3060307495592007,0,0,2
120,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.15322988475875826,6.508130081300813,12.208054344416471,['NQO1'],0.3064597695175165,0,0,1
121,TP53 network WP1742,0.15322988475875826,6.508130081300813,12.208054344416471,['GADD45A'],0.3064597695175165,0,0,1
122,Cysteine and methionine catabolism WP4504,0.15322988475875826,6.508130081300813,12.208054344416471,['SQOR'],0.3064597695175165,0,0,1
123,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.15322988475875826,6.508130081300813,12.208054344416471,['SYTL4'],0.3064597695175165,0,0,1
124,Hypertrophy Model WP516,0.15322988475875826,6.508130081300813,12.208054344416471,['IL1R1'],0.3064597695175165,0,0,1
125,IL1 and megakaryocytes in obesity WP2865,0.15322988475875826,6.508130081300813,12.208054344416471,['IL1R1'],0.3064597695175165,0,0,1
126,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.1640005343593021,6.00703564727955,10.860033202602164,['TNC'],0.3203135436705119,0,0,1
127,Differentiation of white and brown adipocyte WP2895,0.1640005343593021,6.00703564727955,10.860033202602164,['CEBPB'],0.3203135436705119,0,0,1
128,Imatinib and Chronic Myeloid Leukemia WP3640,0.1640005343593021,6.00703564727955,10.860033202602164,['GADD45A'],0.3203135436705119,0,0,1
129,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.16794310634429999,2.796669588080631,4.989622139162208,"['HSPA1B', 'HSPA1A']",0.32547113632616276,0,0,2
130,Endometrial cancer WP4155,0.17246648607631596,2.74738994726079,4.8286816444425416,"['EGF', 'GADD45A']",0.3258115757410775,0,0,2
131,Constitutive Androstane Receptor Pathway WP2875,0.17463500459721754,5.577526132404182,9.73310197463304,['HSP90AA1'],0.3258115757410775,0,0,1
132,ERK Pathway in Huntington's Disease WP3853,0.17463500459721754,5.577526132404182,9.73310197463304,['EGF'],0.3258115757410775,0,0,1
133,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.17463500459721754,5.577526132404182,9.73310197463304,['PRKCQ'],0.3258115757410775,0,0,1
134,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.17463500459721754,5.577526132404182,9.73310197463304,['NFKB2'],0.3258115757410775,0,0,1
135,T-cell receptor (TCR) signaling pathway WP69,0.18157191328260758,2.653842154518041,4.52772935461245,"['PRKCQ', 'MAP3K14']",0.33524807697838704,0,0,2
136,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.1851350068792018,5.205284552845528,8.77959705282628,['EGR1'],0.33524807697838704,0,0,1
137,Pregnane X receptor pathway WP2876,0.1851350068792018,5.205284552845528,8.77959705282628,['HSP90AA1'],0.33524807697838704,0,0,1
138,Prolactin Signaling Pathway WP2037,0.18615153367890772,2.609406952965235,4.3869199385047555,"['SOCS3', 'IRS2']",0.33524807697838704,0,0,2
139,Myometrial relaxation and contraction pathways WP289,0.1863979307999832,2.0640025990903186,3.467259096008781,"['ACTA2', 'PLCG2', 'PRKCQ']",0.33524807697838704,0,0,3
140,Apoptosis Modulation by HSP70 WP384,0.19550223119848886,4.879573170731708,7.964358752104809,['HSPA1A'],0.3441940690114241,0,0,1
141,Urea cycle and metabolism of amino groups WP497,0.19550223119848886,4.879573170731708,7.964358752104809,['PYCR1'],0.3441940690114241,0,0,1
142,Microglia Pathogen Phagocytosis Pathway WP3937,0.19550223119848886,4.879573170731708,7.964358752104809,['PLCG2'],0.3441940690114241,0,0,1
143,Retinoblastoma gene in cancer WP2446,0.19998402918602456,2.484565196221638,3.998951833278219,"['BARD1', 'CDC7']",0.34962242864689613,0,0,2
144,Leptin signaling pathway WP2034,0.20462233920829315,2.4455521472392636,3.8800867388914524,"['SOCS3', 'PLCG2']",0.34989514702335456,0,0,2
145,Urea cycle and associated pathways WP4595,0.2057383464497325,4.592180774748924,7.260927001198675,['PYCR1'],0.34989514702335456,0,0,1
146,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.2057383464497325,4.592180774748924,7.260927001198675,['ETV6'],0.34989514702335456,0,0,1
147,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.2057383464497325,4.592180774748924,7.260927001198675,['UGCG'],0.34989514702335456,0,0,1
148,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.21584500070687276,4.336720867208672,6.649037527948741,['PML'],0.3550082248468302,0,0,1
149,Zinc homeostasis WP3529,0.21584500070687276,4.336720867208672,6.649037527948741,['SLC39A14'],0.3550082248468302,0,0,1
150,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.21584500070687276,4.336720867208672,6.649037527948741,['BCL6'],0.3550082248468302,0,0,1
151,Hippo-Yap signaling pathway WP4537,0.21584500070687276,4.336720867208672,6.649037527948741,['NDRG1'],0.3550082248468302,0,0,1
152,Kallmann's Syndrome WP5074,0.21584500070687276,4.336720867208672,6.649037527948741,['PRKCQ'],0.3550082248468302,0,0,1
153,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.21860473544322923,2.3355004120501786,3.5511051169922707,"['EGF', 'MAP3K14']",0.35719728013599544,0,0,2
154,Glioblastoma signaling pathways WP2261,0.22328462283092204,2.3009743774810536,3.4498692592352254,"['PLCG2', 'PRKCQ']",0.35959207234126983,0,0,2
155,Striated Muscle Contraction Pathway WP383,0.22582382143031743,4.108151476251605,6.112929950897917,['ACTA2'],0.35959207234126983,0,0,1
156,Canonical and non-canonical Notch signaling WP3845,0.22582382143031743,4.108151476251605,6.112929950897917,['HES1'],0.35959207234126983,0,0,1
157,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.22582382143031743,4.108151476251605,6.112929950897917,['CEBPB'],0.35959207234126983,0,0,1
158,B Cell Receptor Signaling Pathway WP23,0.2279724139294228,2.267449097537121,3.352492985496134,"['BCL6', 'PLCG2']",0.3607158448250361,0,0,2
159,Sphingolipid Metabolism (general overview) WP4725,0.23567641572293935,3.902439024390244,5.640177696075957,['UGCG'],0.36146689528058185,0,0,1
160,EPO Receptor Signaling WP581,0.23567641572293935,3.902439024390244,5.640177696075957,['IRS2'],0.36146689528058185,0,0,1
161,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.23567641572293935,3.902439024390244,5.640177696075957,['HGF'],0.36146689528058185,0,0,1
162,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.23567641572293935,3.902439024390244,5.640177696075957,['IRAK2'],0.36146689528058185,0,0,1
163,SARS-CoV-2 mitochondrial interactions WP5038,0.23567641572293935,3.902439024390244,5.640177696075957,['NFKB2'],0.36146689528058185,0,0,1
164,Pathways Regulating Hippo Signaling WP4540,0.23736793139921883,2.2032316598980386,3.168564146621961,"['PRKCQ', 'EPHA2']",0.36184135884027263,0,0,2
165,Sphingolipid Metabolism (integrated pathway) WP4726,0.24540437070449383,3.7163182346109176,5.2208620026467685,['UGCG'],0.3672380348891577,0,0,1
166,Toll-like Receptor Signaling related to MyD88 WP3858,0.24540437070449383,3.7163182346109176,5.2208620026467685,['NFKB2'],0.3672380348891577,0,0,1
167,Type II interferon signaling (IFNG) WP619,0.24540437070449383,3.7163182346109176,5.2208620026467685,['SOCS3'],0.3672380348891577,0,0,1
168,Senescence and Autophagy in Cancer WP615,0.24678395944551396,2.1425329859652074,2.9979221043664213,"['CEBPB', 'CD44']",0.3672380348891577,0,0,2
169,Cell migration and invasion through p75NTR WP4561,0.2550092535585574,3.5471175166297115,4.846978048261641,['EFNA1'],0.36812287025269097,0,0,1
170,Endothelin Pathways WP2197,0.2550092535585574,3.5471175166297115,4.846978048261641,['CALCRL'],0.36812287025269097,0,0,1
171,Gastric Cancer Network 2 WP2363,0.2550092535585574,3.5471175166297115,4.846978048261641,['S100A6'],0.36812287025269097,0,0,1
172,miRNAs involvement in the immune response in sepsis WP4329,0.2550092535585574,3.5471175166297115,4.846978048261641,['NFKB2'],0.36812287025269097,0,0,1
173,Prostaglandin Synthesis and Regulation WP98,0.2550092535585574,3.5471175166297115,4.846978048261641,['S100A6'],0.36812287025269097,0,0,1
174,Pancreatic adenocarcinoma pathway WP4263,0.2562135176958729,2.085071574642127,2.8393339745472503,"['EGF', 'GADD45A']",0.36812287025269097,0,0,2
175,Circadian rhythm related genes WP3594,0.25960006824060927,1.727124183006536,2.3292221798482466,"['EGR1', 'EGR3', 'PML']",0.3708572403437275,0,0,3
176,Sphingolipid pathway WP1422,0.26449261198111673,3.3926299045599153,4.512000865138341,['UGCG'],0.3735771355665491,0,0,1
177,TYROBP causal network in microglia WP3945,0.26449261198111673,3.3926299045599153,4.512000865138341,['IL13RA1'],0.3735771355665491,0,0,1
178,EGF/EGFR signaling pathway WP437,0.2699013181620918,1.6894484412470023,2.212668723005903,"['PLSCR1', 'EGF', 'LIMK2']",0.3776100236973734,0,0,3
179,Hippo-Merlin Signaling Dysregulation WP4541,0.27036877696731937,2.004404593361649,2.6216978915333415,"['CD44', 'EPHA2']",0.3776100236973734,0,0,2
180,Resistin as a regulator of inflammation WP4481,0.2738559742190327,3.2510162601626016,4.210563307417185,['PLCG2'],0.3778667141951689,0,0,1
181,22q11.2 copy number variation syndrome WP4657,0.27508696793408294,1.9788770676399783,2.554073276025027,"['ACTA2', 'HES1']",0.3778667141951689,0,0,2
182,Osteoblast differentiation WP4787,0.27508696793408294,1.9788770676399783,2.554073276025027,"['FZD9', 'PRKCQ']",0.3778667141951689,0,0,2
183,ErbB signaling pathway WP673,0.2798037923823523,1.9539877300613497,2.4887290315701365,"['EGF', 'PLCG2']",0.3783491054213484,0,0,2
184,Focal Adhesion WP306,0.2802487607748888,1.6533646322378717,2.103208177610523,"['EGF', 'HGF', 'TNC']",0.3783491054213484,0,0,3
185,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.2831008494840375,3.120731707317073,3.9382138885776428,['PRKCQ'],0.3783491054213484,0,0,1
186,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.2831008494840375,3.120731707317073,3.9382138885776428,['NDRG1'],0.3783491054213484,0,0,1
187,Oxidation by Cytochrome P450 WP43,0.2831008494840375,3.120731707317073,3.9382138885776428,['CYP39A1'],0.3783491054213484,0,0,1
188,Regulation of toll-like receptor signaling pathway WP1449,0.284518527276854,1.9297129440278724,2.425566010238014,"['IRAK2', 'NFKB2']",0.3783491054213484,0,0,2
189,Wnt signaling in kidney disease WP4150,0.29222872813376966,3.00046904315197,3.6912324290039717,['FZD9'],0.3865459366848805,0,0,1
190,ESC Pluripotency Pathways WP3931,0.2939389280466438,1.8829181757705669,2.3054134961601886,"['EGF', 'FZD9']",0.38676174742979447,0,0,2
191,DNA damage response (only ATM dependent) WP710,0.29864323839645296,1.8603564125036518,2.2482511436621113,"['BCL6', 'NFKB2']",0.3902086552431958,0,0,2
192,Alpha 6 Beta 4 signaling pathway WP244,0.30124108184774717,2.889114724480578,3.466488118619643,['IRS2'],0.3902086552431958,0,0,1
193,Nuclear receptors WP170,0.30124108184774717,2.889114724480578,3.466488118619643,['NR4A1'],0.3902086552431958,0,0,1
194,Neovascularisation processes WP4331,0.31013936394091685,2.7857142857142856,3.2613290953996867,['NFKB2'],0.3955859233940266,0,0,1
195,Prion disease pathway WP3995,0.31013936394091685,2.7857142857142856,3.2613290953996867,['EBF1'],0.3955859233940266,0,0,1
196,Proximal tubule transport WP4917,0.31013936394091685,2.7857142857142856,3.2613290953996867,['SLC22A6'],0.3955859233940266,0,0,1
197,ATM Signaling Pathway WP2516,0.31892500954787995,2.6894449116904964,3.0734957184155878,['GADD45A'],0.40268309286348475,0,0,1
198,Bladder cancer WP2828,0.31892500954787995,2.6894449116904964,3.0734957184155878,['EGF'],0.40268309286348475,0,0,1
199,Cell cycle WP179,0.3220803304881576,1.7551526849107328,1.9885077657041208,"['GADD45A', 'CDC7']",0.40462353076401714,0,0,2
200,CAMKK2  Pathway WP4874,0.3275994358850185,2.5995934959349594,2.9010518435555186,['HMOX1'],0.4094992948562731,0,0,1
201,Signaling of Hepatocyte Growth Factor Receptor WP313,0.3361640423401861,2.515538945712038,2.7423299174384024,['HGF'],0.41399512603471195,0,0,1
202,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.3361640423401861,2.515538945712038,2.7423299174384024,['NFKB2'],0.41399512603471195,0,0,1
203,p38 MAPK Signaling Pathway WP400,0.3361640423401861,2.515538945712038,2.7423299174384024,['HSPB1'],0.41399512603471195,0,0,1
204,Hepatitis C and Hepatocellular Carcinoma WP3646,0.3446202109938658,2.4367378048780486,2.595886770072426,['CD44'],0.4202685499925193,0,0,1
205,Phosphoinositides metabolism WP4971,0.3446202109938658,2.4367378048780486,2.595886770072426,['PLCG2'],0.4202685499925193,0,0,1
206,Ebola Virus Pathway on Host WP4217,0.34994219966202295,1.6435259928963513,1.7256813901105545,"['SOCS3', 'NFKB2']",0.42424195481177773,0,0,2
207,DNA Replication WP466,0.3529693064033991,2.3627124907612713,2.4604677744386025,['CDC7'],0.42424195481177773,0,0,1
208,IL-2 signaling pathway WP49,0.3529693064033991,2.3627124907612713,2.4604677744386025,['SOCS3'],0.42424195481177773,0,0,1
209,Integrated Cancer Pathway WP1971,0.3612126762717078,2.293041606886657,2.3349775845623784,['BARD1'],0.4300150907996521,0,0,1
210,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.3612126762717078,2.293041606886657,2.3349775845623784,['ACTA2'],0.4300150907996521,0,0,1
211,IL-6 signaling pathway WP364,0.3693516512876675,2.2273519163763065,2.2184561049650355,['SOCS3'],0.437620439914298,0,0,1
212,TGF-beta Receptor Signaling WP560,0.377387545538483,2.165311653116531,2.1100586319264156,['EGF'],0.44503248294632436,0,0,1
213,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.3853216567746263,2.106624917600527,2.009039355225676,['HSP90AA1'],0.45225546569791825,0,0,1
214,Glycogen Synthesis and Degradation WP500,0.39315526634639497,2.0510269576379976,1.914737581004022,['HKDC1'],0.4571572864492965,0,0,1
215,Metabolic reprogramming in colon cancer WP4290,0.39315526634639497,2.0510269576379976,1.914737581004022,['PYCR1'],0.4571572864492965,0,0,1
216,ATM Signaling Network in Development and Disease  WP3878,0.4008896396706523,1.9982801751094434,1.826566165895996,['HSPB1'],0.4618544235837007,0,0,1
217,Interleukin-11 Signaling Pathway WP2332,0.4008896396706523,1.9982801751094434,1.826566165895996,['SOCS3'],0.4618544235837007,0,0,1
218,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.4085260262734861,1.9481707317073171,1.7440017667180563,['EGF'],0.4684931493961997,0,0,1
219,Synaptic Vesicle Pathway WP2267,0.4308595281503568,1.8118264322178106,1.5255092315191676,['SLC22A3'],0.4918487764273479,0,0,1
220,G1 to S cell cycle control WP45,0.4452808095270189,1.731029810298103,1.4004899505054753,['GADD45A'],0.506000919917067,0,0,1
221,Rett syndrome causing genes WP4312,0.45933883218308175,1.6571094966268811,1.2891767436741535,['HAP1'],0.5196140635555223,0,0,1
222,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.4899400095396923,1.2263175691995556,0.874943647142168,"['EGR1', 'IRS2']",0.5513572826433317,0,0,2
223,Acute viral myocarditis WP4298,0.492953766917894,1.4971857410881801,1.0590191950276435,['NFKB2'],0.5513572826433317,0,0,1
224,Nonalcoholic fatty liver disease WP4396,0.4940161252484252,1.2166411042944785,0.8579596365615046,"['SOCS3', 'IRS2']",0.5513572826433317,0,0,2
225,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.4994231788610231,1.468821905200184,1.0198052355557625,['FZD9'],0.5549146431789146,0,0,1
226,3q29 copy number variation syndrome WP4906,0.5058105410689977,1.4415085817524842,0.9825223095066712,['TFRC'],0.5570600672566054,0,0,1
227,MET in type 1 papillary renal cell carcinoma WP4205,0.5058105410689977,1.4415085817524842,0.9825223095066712,['HGF'],0.5570600672566054,0,0,1
228,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.5183432409349746,1.389808362369338,0.9132675756716012,['FZD9'],0.5683588168146652,0,0,1
229,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5244906085219215,1.3653187847667951,0.8810781088115632,['EGR1'],0.5725880005697834,0,0,1
230,MECP2 and Associated Rett Syndrome WP3584,0.5305599867198405,1.3416736753574432,0.8503826297010082,['BCL6'],0.576695637738957,0,0,1
231,Melanoma WP4685,0.5365523589655363,1.3188300950806118,0.8210919166354173,['GADD45A'],0.5806843711748229,0,0,1
232,Ras signaling WP4223,0.5412961666026181,1.1113058720420683,0.6821069943260598,"['PLCG2', 'EPHA2']",0.5820479575015078,0,0,2
233,Head and Neck Squamous Cell Carcinoma WP4674,0.5424686963914054,1.2967479674796747,0.7931233430000267,['NFKB2'],0.5820479575015078,0,0,1
234,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.5597710295211702,1.2347077042198993,0.7164113085433288,['GADD45A'],0.5980459717106519,0,0,1
235,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.5709430076234903,1.196529080675422,0.6706137311163124,['FZD9'],0.607386178322862,0,0,1
236,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.5818331408695177,1.1606297779395705,0.6285640932254616,['PRKCQ'],0.6163486661753366,0,0,1
237,Amino Acid metabolism WP3925,0.5924484974690615,1.1268115942028984,0.589876104451224,['PYCR1'],0.6249456724357189,0,0,1
238,Small cell lung cancer WP4658,0.6275363412534233,1.0224646983311938,0.476421204506418,['GADD45A'],0.6591768290477136,0,0,1
239,Androgen receptor signaling pathway WP138,0.6369980468190094,0.9960913070669168,0.4492259133288017,['LIMK2'],0.6635396321031348,0,0,1
240,G Protein Signaling Pathways WP35,0.6369980468190094,0.9960913070669168,0.4492259133288017,['PRKCQ'],0.6635396321031348,0,0,1
241,Male infertility WP4673,0.6416389197031082,0.9834053720284038,0.4363660368517943,['NQO1'],0.6656005391111081,0,0,1
242,Wnt signaling WP428,0.6682713800759038,0.913558106169297,0.3682195801987386,['FZD9'],0.6903629959461816,0,0,1
243,7q11.23 copy number variation syndrome WP4932,0.6808402535661852,0.8822062084257206,0.3391443947763205,['FZD9'],0.7004529357676802,0,0,1
244,Mesodermal commitment pathway WP2857,0.7335144552902306,0.7602821616451458,0.2356175046216104,['HMGA2'],0.7515516959940887,0,0,1
245,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7501517439877882,0.7244700250740825,0.20827047444127264,['FZD9'],0.7654609632528451,0,0,1
246,Calcium Regulation in the Cardiac Cell WP536,0.771723243901243,0.6796106118955927,0.17610701233785556,['PRKCQ'],0.7842715893305316,0,0,1
247,Ectoderm Differentiation WP2858,0.7775391587673965,0.6677880571909167,0.16802967985783385,['TNFRSF11B'],0.7866851253377346,0,0,1
248,Regulation of Actin Cytoskeleton WP51,0.7803916443350327,0.6620283510527413,0.16415613760966738,['EGF'],0.7866851253377346,0,0,1
249,Hepatitis B infection WP4666,0.7887327944470306,0.6453252032520326,0.1531535327273423,['EGR3'],0.7919003960311553,0,0,1
250,Ciliary landscape WP4352,0.9278892553383208,0.37897993511954825,0.028363953686202825,['CDH23'],0.9278892553383208,0,0,1
